LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

“The findings offer the first real solution in two decades for managing this rash, which frequently impacts patients receiving targeted therapies for colorectal cancer,” said study co-author ...

"The findings offer the first real solution in two decades for managing this rash, which frequently impacts patients receiving targeted therapies for colorectal cancer," said study co-author Zev ...

Furthermore, those diagnosed with marijuana addiction before they were stricken with colon cancer were 24.4 times more likely ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Medical staff and patients with CRC reported that intermittent symptom management did not provide sufficient support to patients at home.

“For patients with [colorectal cancer], ensuring adequate vitamin D levels may help support immune surveillance and potentially improve outcomes when used alongside standard therapies ...

study says Lifestyle changes boost longevity for cancer survivors, study suggests Colon cancer linked to higher risk of heart-related death "By offering an effective screening approach equally to ...